PSORIASIS MARKET, EPIDEMIOLOGY, AND MARKET FORECAST ANALYSIS REPORT

June 29 21:10 2021
PSORIASIS MARKET, EPIDEMIOLOGY, AND MARKET FORECAST ANALYSIS REPORT

DelveInsight Business Research LLP
DelveInsight’s “Psoriasis Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Psoriasis, historical and forecasted epidemiology as well as the Psoriasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

What is Psoriasis?

Psoriasis is a chronic, immune mediated inflammatory skin disease characterized by the presence of papules and plaques occurring most commonly on the elbows, knees, scalp, and lower back, but is not limited to these areas.

How Psoriasis affected population?

Psoriasis Epidemiology –

  • Approximately 8 million Americans are affected by psoriasis, resulting in a prevalence of 2–4% in the United States, according to population-based estimates.
  • Psoriasis can occur at any age, although most patients present with the condition before 35 years old.
  • Psoriasis is a chronic immune-mediated skin disorder that affects about 2–3% of the population worldwide. Psoriasis affects males and females equally globally.

To know more, request sample pages @Psoriasis Market Landscape

Psoriasis Market Outlook

Topical therapies have remained the first-line choice for the psoriasis treatment, mainly mild to moderate cases.

Topical treatments are applied to the skin and are often the first treatment recommended to a newly diagnosed person. Topicals can be purchased over the counter or by prescription. Topical treatments – medications applied to the skin – typically are your first line of defense when treating psoriasis. Topicals slow down or normalize excessive cell reproduction and reduce inflammation caused by psoriasis. There are several effective treatment therapies for psoriasis, many of which can be purchased over the counter (OTC). However, some therapies are only available by prescription from the health care provider.

The Psoriasis market size shall grow during the forecast period owing to the launch of upcoming therapies, changing lifestyle, increasing disposable income, and higher adult population

Which are the leading companies in Psoriasis market?

 

Of the Psoriasisemerging therapies, the most anticipated product to get launched is Bimekizumab (UCB), Mirikizumab (Eli Lilly and Company), etc. Apart from this, other products include BI 730357 (Boehringer Ingelheim), JTE-451 (Akros Pharma Inc.), KD025 (Kadmon Pharmaceuticals), PF-06826647 (Pfizer) and XP23829 (Arbor Pharmaceuticals/Dr. Reddy’s Laboratories), Tapinarof (Dermavant) and ARQ-151 (Arcutis Biotherapeutics), PF-06700841 (Pfizer) etc.

Table of contents

1. Key Insights

2. Executive Summary of Psoriasis

3. Competitive Intelligence Analysis for Psoriasis

4. Psoriasis: Market Overview at a Glance

4.1. Psoriasis Total Market Share (%) Distribution in 2017

4.2. Psoriasis Total Market Share (%) Distribution in 2030

5. Psoriasis: Disease Background and Overview

5.1. Introduction

5.2. Sign and Symptoms 

5.3. Pathophysiology 

5.4. Risk Factors 

5.5. Diagnosis 

6. Patient Journey

7. Psoriasis Epidemiology and Patient Population

7.1. Epidemiology Key Findings

7.2. Assumptions and Rationale: 7MM

7.3. Epidemiology Scenario: 7MM

7.3.1. Psoriasis Epidemiology Scenario in the 7MM (2017-2030)

7.4. United States Epidemiology

7.4.1. Psoriasis Epidemiology Scenario in the United States (2017-2030)

7.5. EU-5 Country-wise Epidemiology

7.5.1. Germany Epidemiology

7.5.1.1. Psoriasis Epidemiology Scenario in Germany (2017-2030)

7.5.2. France Epidemiology

7.5.2.1. Psoriasis Epidemiology Scenario in France (2017-2030)

7.5.3. Italy Epidemiology

7.5.3.1. Psoriasis Epidemiology Scenario in Italy (2017-2030)

7.5.4. Spain Epidemiology

7.5.4.1. Psoriasis Epidemiology Scenario in Spain (2017-2030)

7.5.5. United Kingdom Epidemiology

7.5.5.1. Psoriasis Epidemiology Scenario in the United Kingdom (2017-2030)

7.5.6. Japan Epidemiology

7.5.6.1. Psoriasis Epidemiology Scenario in Japan (2017-2030)

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Psoriasis Treatment and Management

8.2. Psoriasis Treatment Algorithm 

9. Unmet Needs

10. Key Endpoints of Psoriasis Treatment

11. Marketed Products

11.1. List of Marketed Products in the 7MM

11.2. Drug Name: Company Name

11.2.1. Product Description

11.2.2. Regulatory Milestones

11.2.3. Other Developmental Activities

11.2.4. Pivotal Clinical Trials

11.2.5. Summary of Pivotal Clinical Trial

List to be continued in report

12. Emerging Therapies

12.1. Key Cross

12.2. Drug Name: Company Name

12.2.1. Product Description

12.2.2. Other Developmental Activities

12.2.3. Clinical Development

12.2.4. Safety and Efficacy

12.2.5. Product Profile

List to be continued in report

13. Psoriasis: Seven Major Market Analysis

13.1. Key Findings

13.2. Psoriasis Market Size in 7MM

13.3. Psoriasis Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

15.1. United States: Market Size

15.1.1. Psoriasis Total Market Size in the United States

15.1.2. Psoriasis Market Size by Therapies in the United States

15.2. EU-5 countries: Market Size and Outlook

15.3. Germany Market Size

15.3.1. Psoriasis Total Market Size in Germany

15.3.2. Psoriasis Market Size by Therapies in Germany

15.4. France Market Size

15.4.1. Psoriasis Total Market Size in France

15.4.2. Psoriasis Market Size by Therapies in France

15.5. Italy Market Size

15.5.1. Psoriasis Total Market Size in Italy

15.5.2. Psoriasis Market Size by Therapies in Italy

15.6. Spain Market Size

15.6.1. Psoriasis Total Market Size in Spain

15.6.2. Psoriasis Market Size by Therapies in Spain

15.7. United Kingdom Market Size

15.7.1. Psoriasis Total Market Size in the United Kingdom

15.7.2. Psoriasis Market Size by Therapies in the United Kingdom

15.8. Japan Market Outlook

15.8.1. Japan Market Size

15.8.2. Psoriasis Total Market Size in Japan

15.8.3. Psoriasis Market Size by Therapies in Japan

16. Access and Reimbursement Overview of Psoriasis

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

*The table of contents is not exhaustive; the final content may vary. 

Request sample pages for more information on Psoriasis Market Report

Media Contact
Company Name: DelveInsight
Contact Person: Priya Maurya
Email: Send Email
Phone: +919650213330
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/


Warning: count(): Parameter must be an array or an object that implements Countable in /home/ghaziabadonline/dispurnewsflash.com/wp-content/themes/gadgetine-theme/includes/single/post-tags-categories.php on line 7